Optimising the Therapeutic Interval for Biologics in Patients with Psoriasis

In our clinical experience, more than half of patients do not present a complete response to biologic drugs, or drug loses its efficacy over time. Plasma determinations of drug and anti-drug antibodies levels are an objective tool for optimisation in these patients; however, established therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales: Dodero-Anillo, Jose Manuel, Lozano-Cuadra, Inmaculada Concepcion, Rios-Sanchez, Esmeralda, Pedrosa-Martinez, Maria Jose, Ruiz-Carrascosa, Jose Carlos, Galan-Gutierrez, Manuel, Armario-Hita, Jose Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9787329/
https://www.ncbi.nlm.nih.gov/pubmed/36556440
http://dx.doi.org/10.3390/life12122075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9787329/
https://www.ncbi.nlm.nih.gov/pubmed/36556440
http://dx.doi.org/10.3390/life12122075

Ejemplares similares